C3 Diagnostic And Pathology Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 28-05-2024
- Paid Up Capital ₹ 0.10 M
as on 28-05-2024
- Company Age 3 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
About C3 Diagnostic And Pathology
The Company is engaged in the Non-Profit Organizations Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Manisha Jhawar and Manan Jhawar serve as directors at the Company.
- CIN/LLPIN
U85300MP2021PTC057637
- Company No.
057637
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Sep 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at C3 Diagnostic And Pathology?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manisha Jhawar  | Director | 26-Sep-2021 | Current |
| Manan Jhawar | Director | 26-Sep-2021 | Current |
Financial Performance of C3 Diagnostic And Pathology.
C3 Diagnostic And Pathology Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of C3 Diagnostic And Pathology?
Unlock access to C3 Diagnostic And Pathology's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
C3 Pharmacy Hub Private LimitedActive 2 years 11 monthsManisha Jhawar and Manan Jhawar are mutual person
- Kcl Stock Broking LimitedActive 16 years 11 months
Manisha Jhawar and Manan Jhawar are mutual person
- C3 Realities & Facilities Private LimitedActive 2 years 10 months
Manisha Jhawar and Manan Jhawar are mutual person
- Atmanirbhar For The Excellence Private LimitedActive 4 years 1 month
Manisha Jhawar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at C3 Diagnostic And Pathology?
C3 Diagnostic And Pathology has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of C3 Diagnostic And Pathology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped C3 Diagnostic And Pathology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
